Virpax Pharmaceuticals In...

0.25
0.00 (1.63%)
At close: Apr 28, 2025, 9:58 AM

Virpax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
-12.07B -15.19M -21.65M -12.06M -4.34M -3.31M -2.64M
n/a n/a n/a n/a n/a n/a n/a
134.7M 544.77K 745.03K 974.23K 1.47M 678.15K 384.95K
-4.78M 4.19M 4.05M -2.71M -13.09K 7.95K -13.13K
-4.78B 599.43K 745.03K -61.82K 153.22K 564.64K 14.98K
n/a n/a n/a n/a n/a n/a n/a
-4.78M 4.19M 3.06M -3.4M 1.33M 931.89K 441.37K
-16.71B -9.85M -17.85M -14.54M -1.38M -1.13M -1.8M
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a -1.5M 72.1K 500K 554.77K
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
9.08B n/a n/a -5.19M -50.88K 625K n/a
9.08B n/a n/a 51.33M 1.4M 1.13M 1.67M
-7.63B -9.85M -17.85M 36.79M 13.26K -6.83K -124.87K
-16.71B -9.85M -17.85M -14.54M -1.38M -1.13M -1.8M